antigens
| 4 min read
Robert Georgantas aims to expand the development of mRNA-based vaccines for a range of infectious diseases and cancers.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Rapid DNA-to-mRNA workflows help scientists keep pace with rapidly evolving cancer through personalized vaccines.
Understand how a human-relevant in vitro model can be used to improve next generation risk assessment (NGRA).
Explore the role of microphysiological systems in advancing human-relevant liver toxicity testing and mechanistic evaluation.
